View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Alan Vandenberghe ... (+7)
  • Alan Vandenberghe
  • Alexander Makar
  • Cedric Duinslaeger
  • Jason Kalamboussis
  • Ruben Devos
  • Sandra Cauwenberghs
  • Thomas Couvreur

Morning Note: ABN NA, ADYEN NA, AGS BB, ATEB BB, FUR NA, MITRA BB, ONT...

ABN Amro: A lower quarter, pressure on top line Adyen: Uber chooses Adyen for 3D Secure implementation Ageas: A good start, Asia ex RG delivers solid results Atenor: 1Q19 and a sizeable move in Warsaw, Poland Fugro: Multi-client OBN survey contact with CGG Mithra: Tibelia approved in Canada Ontex: No real transformation PostNL: No near-term dividend but risk-return inviting Sequana Medical: Alfapump included into German DGVS guidelines

Alan Vandenberghe ... (+8)
  • Alan Vandenberghe
  • Cedric Duinslaeger
  • Guy Sips
  • Jan Opdecam
  • Joachim Vansanten
  • Ruben Devos
  • Sandra Cauwenberghs
  • Wim Hoste

Morning Note: BEFB BB, BREB BB, EURN BB, EXM BB, GIMB BB, GREEN BB, KI...

Befimmo: First sale of 2019 closed – € 93m Brederode: 1Q19, Steady NAV growth (+7.3%) Euronav: Euronav: 1Q19 update in line EXMAR: Contracting two VLGCs with Jiangnan Gimv: Life sciences team establishes advisory board Greenyard: Strategic partnership with Tesco for frozen Kinepolis: Canadian expansion not yet in Endgame modus Nyrstar: Update on support for Recapitalization plan Orange Belgium: Expands portfolio of IT services Sequana Medical: Heart Failure – first data coming up May 27th...

Alexander Makar ... (+6)
  • Alexander Makar
  • Cedric Duinslaeger
  • Jan Opdecam
  • Jason Kalamboussis
  • Joachim Vansanten
  • Sandra Cauwenberghs

Morning Note: AED BB, AGS BB, QFG BB, SEQUA:BB, VPK NA

Aedifica: Sale of hotel portfolio Ageas: REinsurance miracles Quest for Growth: Upgrade to Accumulate Sequana Medical: Feedback webcast FY18 Vopak: Agreement on strategic assets, rating upgraded

Guy Sips ... (+3)
  • Guy Sips
  • Lenny Van Steenhuyse
  • Sandra Cauwenberghs

Morning Note: OXUR BB, RES BB, SEQUA:BB

Oxurion: THR-317 phase II fully recruited, results 3Q19 Resilux: Adopting a share buy-back programme of € 2.5m Sequana Medical: FY18 - on track to deliver on heart in 2019

Sandra Cauwenberghs
  • Sandra Cauwenberghs

SEQUANA: Pumping ALFA by tapping into two major disease areas

Sequana Medical is a commercial medtech providing an implantable pump system to manage fluid balance within the body. The alfapump® is designed to transport fluid from the peritoneal cavity into the bladder.

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch